Wafergen Reports Eight-Fold Increase in Q3 Revenues as Net Loss Swells

WaferGen reported an approximately eight-fold increase in revenues, but said that net loss swelled by more than 70 percent in the third quarter, the first full quarter of commercial availability for the company's flagship real-time PCR system.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.